BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8186385)

  • 1. Use of transgenic mice to study myc family gene function in normal mammalian development and in cancer.
    Morgenbesser SD; DePinho RA
    Semin Cancer Biol; 1994 Feb; 5(1):21-36. PubMed ID: 8186385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Abnormal expression of several oncogenes during hepatocarcinogenesis in WHV/myc transgenic mice].
    Liu P; Zhao Z; Dominique B
    Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):110-2. PubMed ID: 10488423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF beta regulation of cell proliferation.
    Moses HL; Arteaga CL; Alexandrow MG; Dagnino L; Kawabata M; Pierce DF; Serra R
    Princess Takamatsu Symp; 1994; 24():250-63. PubMed ID: 8983080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and function of myc family genes.
    Zimmerman K; Alt FW
    Crit Rev Oncog; 1990; 2(1):75-95. PubMed ID: 2091750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of myc family genes during murine development.
    Zimmerman KA; Yancopoulos GD; Collum RG; Smith RK; Kohl NE; Denis KA; Nau MM; Witte ON; Toran-Allerand D; Gee CE
    Nature; 1986 Feb 27-Mar 5; 319(6056):780-3. PubMed ID: 2419762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The myc family of oncogenes and their presence and importance in small-cell lung carcinoma and other tumour types.
    Prins J; De Vries EG; Mulder NH
    Anticancer Res; 1993; 13(5A):1373-85. PubMed ID: 8239508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYC oncogenes and human neoplastic disease.
    Nesbit CE; Tersak JM; Prochownik EV
    Oncogene; 1999 May; 18(19):3004-16. PubMed ID: 10378696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.
    Chen H; Liu J; Zhao CQ; Diwan BA; Merrick BA; Waalkes MP
    Toxicol Appl Pharmacol; 2001 Sep; 175(3):260-8. PubMed ID: 11559025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis.
    Murakami H; Sanderson ND; Nagy P; Marino PA; Merlino G; Thorgeirsson SS
    Cancer Res; 1993 Apr; 53(8):1719-23. PubMed ID: 8467484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential alteration of stem and other cell populations in ducts and lobules of TGFalpha and c-Myc transgenic mouse mammary epithelium.
    Chepko G; Slack R; Carbott D; Khan S; Steadman L; Dickson RB
    Tissue Cell; 2005 Oct; 37(5):393-412. PubMed ID: 16137731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of myc amplification and overexpression in cell growth, differentiation and death.
    Koskinen PJ; Alitalo K
    Semin Cancer Biol; 1993 Feb; 4(1):3-12. PubMed ID: 8448376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
    McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
    Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory imbalances in cell proliferation and cell death during oncogenesis in transgenic mice.
    Merlino G
    Semin Cancer Biol; 1994 Feb; 5(1):13-20. PubMed ID: 8186384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of viral-host protein interactions and tumorigenesis in transgenic mice.
    Van Dyke TA
    Semin Cancer Biol; 1994 Feb; 5(1):47-60. PubMed ID: 8186388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
    Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
    Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H-2/myc, E mu/myc, and c-myc transgenic mice: potent sources of early hematopoietic cell lines.
    Roland J; Morello D
    Cell Growth Differ; 1993 Nov; 4(11):891-900. PubMed ID: 8297795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of intracisternal A-particle retrotransposons in primary tumors of oncogene-expressing transgenic mice.
    Dupressoir A; Heidmann T
    Oncogene; 1997 Jun; 14(24):2951-8. PubMed ID: 9205102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicopy c-Myc transgene as a nuclear label: overgrowth of Myctg50 cells in allophenic mice.
    Augustin M; Klopp N; Ewald K; Jockusch H
    Cell Biol Int; 1998; 22(6):401-11. PubMed ID: 10328848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted expression of c-Myc in the epidermis alters normal proliferation, differentiation and UV-B induced apoptosis.
    Waikel RL; Wang XJ; Roop DR
    Oncogene; 1999 Aug; 18(34):4870-8. PubMed ID: 10490820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cis-acting elements known to regulate c-myc expression ex vivo are not sufficient for correct transcription in vivo.
    Lavenu A; Pournin S; Babinet C; Morello D
    Oncogene; 1994 Feb; 9(2):527-36. PubMed ID: 8290263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.